Private company

Rebus Holdings, Inc.

Rebus Holdings, Inc. is an American pharmaceutical preparations company, incorporated in Delaware.1 It is headquartered in Westlake Village, California.1

Last updated Oct 20, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersWestlake Village, California1
  • Incorporated inDE2
  • Business address2629 Townsgate Rd, Suite 215, Westlake Village, Ca 913612
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345678-$664.0K in 2022−79% since 2016
-$6.0M-$4.0M-$2.0M02016: -$3.2M-$3.2M20162017: -$5.9M-$5.9M2017+83%2018: -$724.0K-$724.0K2018−88%2019: -$609.0K-$609.0K2019−16%2020: -$2.5M-$2.5M2020+307%2021: -$1.0M-$1.0M2021−59%2022: -$664.0K-$664.0K2022−35%
Net income345678-$1.0M in 2022−68% since 2016
-$15.0M-$10.0M-$5.0M0$5.0M2016: -$3.2M-$3.2M20162017: -$11.1M-$11.1M2017+248%2018: -$12.0K-$12.0K2018−100%2019: -$934.0K-$934.0K2019+7683%2020: -$6.3M-$6.3M2020+574%2021: $2.7M$2.7M20212022: -$1.0M-$1.0M2022
Fiscal year20162017201820192020202120222023
Research and development$1.1M3$1.7M4$208.0K5$44.0K6$18.0K7$494.0K8$239.0K8
Operating expenses$1.0M8$664.0K8
Operating income-$3.2M3-$5.9M4-$724.0K5-$609.0K6-$2.5M7-$1.0M8-$664.0K8
Income before tax$2.7M8-$1.0M8
Income tax$06$07$07
Net income-$3.2M3-$11.1M4-$12.0K5-$934.0K6-$6.3M7$2.7M8-$1.0M8
Earnings per share-$10.937$0.358-$0.038
Earnings per share (diluted)-$0.225-$0.145-$10.937-$0.078-$0.038
Shares (weighted, basic)7.6M shares831.8M shares8
Shares (weighted, diluted)21.1M shares831.8M shares8

Compare Rebus Holdings, Inc. with another company

Corporate structure

Rebus Holdings, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Rebus Holdings, Inc.

  • SABBY MANAGEMENT, LLC Filed SC 13G/A on Rebus Holdings, Inc., latest Jan 10, 2023
  • Rebus Holdings, Inc. Westlake Village, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Rebus Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$5.0K8 Dec 31, 2022$711.0K8 Dec 31, 2021−99.3%

Leadership

Who has led Rebus Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Craig A. Dionne2014–2015
  2. Christopher P. Lowe2016

President

  1. Craig A. Dionne2014–2015
  2. Christopher P. Lowe2016

Chief financial officer

  1. Craig A. Dionne2014–2015

Chief operating officer

  1. Russell Richerson2014
201520202025
Board members and other officers (9)

Former names

  • Inspyr Therapeutics, Inc.Aug 2, 2016 to Oct 12, 20212
  • GENSPERA INCDec 12, 2007 to Jul 25, 20162

Timeline

  1. Nov 16, 20228-K Change of auditor22
  2. Oct 13, 20228-K Change of auditor23
  3. Oct 12, 20218-K Other events24
  4. Oct 12, 20218-K Other events25
  5. Oct 5, 20218-K Entered a material agreement; Change to shareholders' rights; Executive or director change26
  6. Aug 18, 2016New chief executive Christopher P. Lowe becomes CEO12
  7. Dec 15, 2014New chief executive Craig A. Dionne becomes CEO13

Filings

20 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 5 major events, 1 large holders, 6 other. The latest 20:

  1. Aug 21, 202310-Q EDGAR
  2. Aug 14, 2023NT 10-Q EDGAR
  3. May 15, 202310-Q EDGAR
  4. Mar 31, 202310-K EDGAR
  5. Jan 10, 2023SC 13G/A SABBY 13GA RBSH 1.10.23 EDGAR
  6. Nov 21, 202210-Q EDGAR
  7. Nov 16, 20228-K EDGAR
  8. Nov 14, 2022NT 10-Q EDGAR
  9. Oct 13, 20228-K EDGAR
  10. Aug 12, 202210-Q EDGAR
  11. May 13, 202210-Q EDGAR
  12. Mar 31, 202210-K EDGAR
  13. Dec 9, 2021EFFECT EDGAR
  14. Dec 9, 2021424B3 EDGAR
  15. Dec 8, 2021CORRESP EDGAR
  16. Dec 3, 2021S-1/A EDGAR
  17. Nov 12, 202110-Q EDGAR
  18. Oct 12, 20218-K/A EDGAR
  19. Oct 12, 20218-K EDGAR
  20. Oct 5, 20218-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Rebus Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARRebus Holdings, Inc.1
  • CIK0001421204
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address2629 Townsgate Rd, Suite 215, Westlake Village, CA 913611
  • Phone(210) 479-81121
  • Shares outstanding32,132,907 as of Aug 13, 202310
  • Public float$766.0K as of Jun 30, 20228
  • On EDGAR sinceDec 12, 20071
  • Filings386 in all: 8-K (133), 10-Q (44), 424B3 (30), D (20), EFFECT (19), 10-K (15), S-1 (13), 3 (11)1
    All 32 form types

    4 (11), CORRESP (11), S-1/A (10), UPLOAD (10), POS AM (8), D/A (7), NT 10-Q (7), SC 13G (6), SC 13G/A (5), DEF 14C (4), PRE 14C (4), 8-K/A (3), NT 10-K (2), PRE 14A (2), S-8 (2), 10-K/A (1), 424B4 (1), 8-A12G (1), AW (1), DEF 14A (1), PRER14C (1), REGDEX (1), RW (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2023
    Quarterly report (10-Q) Aug 21, 2023
    Proxy statement (DEF 14A) Oct 6, 2015
    Latest 8-K (8-K) Nov 16, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
    SEC EDGAROther events
  25. 25
    SEC EDGAROther events
  26. 26
  27. 27